Cargando…

Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study

BACKGROUND: In Aotearoa New Zealand, 90% of patients with notified leptospirosis (a zoonotic bacterial disease) have been men working in agricultural industries. However, since 2008, the epidemiology of notified cases has been gradually changing, that is, more women are affected; there are more case...

Descripción completa

Detalles Bibliográficos
Autores principales: Nisa, Shahista, Vallee, Emilie, Marshall, Jonathan, Collins-Emerson, Julie, Yeung, Polly, Prinsen, Gerard, Douwes, Jeroen, Baker, Michael G, Wright, Jackie, Quin, Tanya, Holdaway, Maureen, Wilkinson, David A, Fayaz, Ahmed, Littlejohn, Stuart, Benschop, Jackie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288348/
https://www.ncbi.nlm.nih.gov/pubmed/37289491
http://dx.doi.org/10.2196/47900
_version_ 1785062066496733184
author Nisa, Shahista
Vallee, Emilie
Marshall, Jonathan
Collins-Emerson, Julie
Yeung, Polly
Prinsen, Gerard
Douwes, Jeroen
Baker, Michael G
Wright, Jackie
Quin, Tanya
Holdaway, Maureen
Wilkinson, David A
Fayaz, Ahmed
Littlejohn, Stuart
Benschop, Jackie
author_facet Nisa, Shahista
Vallee, Emilie
Marshall, Jonathan
Collins-Emerson, Julie
Yeung, Polly
Prinsen, Gerard
Douwes, Jeroen
Baker, Michael G
Wright, Jackie
Quin, Tanya
Holdaway, Maureen
Wilkinson, David A
Fayaz, Ahmed
Littlejohn, Stuart
Benschop, Jackie
author_sort Nisa, Shahista
collection PubMed
description BACKGROUND: In Aotearoa New Zealand, 90% of patients with notified leptospirosis (a zoonotic bacterial disease) have been men working in agricultural industries. However, since 2008, the epidemiology of notified cases has been gradually changing, that is, more women are affected; there are more cases associated with occupations traditionally not considered high risk in New Zealand; infecting serovars have changed; and many patients experience symptoms long after infection. We hypothesized that there is a shift in leptospirosis transmission patterns with substantial burden on affected patients and their families. OBJECTIVE: In this paper, we aimed to describe the protocols used to conduct a nationwide case-control study to update leptospirosis risk factors and follow-up studies to assess the burden and sources of leptospirosis in New Zealand. METHODS: This study used a mixed methods approach, comprising a case-control study and 4 substudies that involved cases only. Cases were recruited nationwide, and controls were frequency matched by sex and rurality. All participants were administered a case-control questionnaire (study 1), with cases being interviewed again at least 6 months after the initial survey (study 2). A subset of cases from two high-risk populations, that is, farmers and abattoir workers, were further engaged in a semistructured interview (study 3). Some cases with regular animal exposure had their in-contact animals (livestock for blood and urine and wildlife for kidney) and environment (soil, mud, and water) sampled (study 4). Patients from selected health clinics suspected of leptospirosis also had blood and urine samples collected (study 5). In studies 4 and 5, blood samples were tested using the microscopic agglutination test to test for antibody titers against Leptospira serovars Hardjo type bovis, Ballum, Tarassovi, Pomona, and Copenhageni. Blood, urine, and environmental samples were also tested for pathogenic Leptospira DNA using polymerase chain reaction. RESULTS: Participants were recruited between July 22, 2019, and January 31, 2022, and data collection for the study has concluded. In total, 95 cases (July 25, 2019, to April 13, 2022) and 300 controls (October 19, 2019, to January 26, 2022) were interviewed for the case-control study; 91 cases participated in the follow-up interviews (July 9, 2020, to October 25, 2022); 13 cases participated in the semistructured interviews (January 26, 2021, to January 19, 2022); and 4 cases had their in-contact animals and environments sampled (October 28, 2020, and July 29, 2021). Data analysis for study 3 has concluded and 2 manuscripts have been drafted for review. Results of the other studies are being analyzed and the specific results of each study will be published as individual manuscripts.. CONCLUSIONS: The methods used in this study may provide a basis for future epidemiological studies of infectious diseases. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/47900
format Online
Article
Text
id pubmed-10288348
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-102883482023-06-24 Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study Nisa, Shahista Vallee, Emilie Marshall, Jonathan Collins-Emerson, Julie Yeung, Polly Prinsen, Gerard Douwes, Jeroen Baker, Michael G Wright, Jackie Quin, Tanya Holdaway, Maureen Wilkinson, David A Fayaz, Ahmed Littlejohn, Stuart Benschop, Jackie JMIR Res Protoc Protocol BACKGROUND: In Aotearoa New Zealand, 90% of patients with notified leptospirosis (a zoonotic bacterial disease) have been men working in agricultural industries. However, since 2008, the epidemiology of notified cases has been gradually changing, that is, more women are affected; there are more cases associated with occupations traditionally not considered high risk in New Zealand; infecting serovars have changed; and many patients experience symptoms long after infection. We hypothesized that there is a shift in leptospirosis transmission patterns with substantial burden on affected patients and their families. OBJECTIVE: In this paper, we aimed to describe the protocols used to conduct a nationwide case-control study to update leptospirosis risk factors and follow-up studies to assess the burden and sources of leptospirosis in New Zealand. METHODS: This study used a mixed methods approach, comprising a case-control study and 4 substudies that involved cases only. Cases were recruited nationwide, and controls were frequency matched by sex and rurality. All participants were administered a case-control questionnaire (study 1), with cases being interviewed again at least 6 months after the initial survey (study 2). A subset of cases from two high-risk populations, that is, farmers and abattoir workers, were further engaged in a semistructured interview (study 3). Some cases with regular animal exposure had their in-contact animals (livestock for blood and urine and wildlife for kidney) and environment (soil, mud, and water) sampled (study 4). Patients from selected health clinics suspected of leptospirosis also had blood and urine samples collected (study 5). In studies 4 and 5, blood samples were tested using the microscopic agglutination test to test for antibody titers against Leptospira serovars Hardjo type bovis, Ballum, Tarassovi, Pomona, and Copenhageni. Blood, urine, and environmental samples were also tested for pathogenic Leptospira DNA using polymerase chain reaction. RESULTS: Participants were recruited between July 22, 2019, and January 31, 2022, and data collection for the study has concluded. In total, 95 cases (July 25, 2019, to April 13, 2022) and 300 controls (October 19, 2019, to January 26, 2022) were interviewed for the case-control study; 91 cases participated in the follow-up interviews (July 9, 2020, to October 25, 2022); 13 cases participated in the semistructured interviews (January 26, 2021, to January 19, 2022); and 4 cases had their in-contact animals and environments sampled (October 28, 2020, and July 29, 2021). Data analysis for study 3 has concluded and 2 manuscripts have been drafted for review. Results of the other studies are being analyzed and the specific results of each study will be published as individual manuscripts.. CONCLUSIONS: The methods used in this study may provide a basis for future epidemiological studies of infectious diseases. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/47900 JMIR Publications 2023-06-08 /pmc/articles/PMC10288348/ /pubmed/37289491 http://dx.doi.org/10.2196/47900 Text en ©Shahista Nisa, Emilie Vallee, Jonathan Marshall, Julie Collins-Emerson, Polly Yeung, Gerard Prinsen, Jeroen Douwes, Michael G Baker, Jackie Wright, Tanya Quin, Maureen Holdaway, David A Wilkinson, Ahmed Fayaz, Stuart Littlejohn, Jackie Benschop. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 08.06.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Nisa, Shahista
Vallee, Emilie
Marshall, Jonathan
Collins-Emerson, Julie
Yeung, Polly
Prinsen, Gerard
Douwes, Jeroen
Baker, Michael G
Wright, Jackie
Quin, Tanya
Holdaway, Maureen
Wilkinson, David A
Fayaz, Ahmed
Littlejohn, Stuart
Benschop, Jackie
Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study
title Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study
title_full Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study
title_fullStr Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study
title_full_unstemmed Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study
title_short Leptospirosis in Aotearoa New Zealand: Protocol for a Nationwide Case-Control Study
title_sort leptospirosis in aotearoa new zealand: protocol for a nationwide case-control study
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288348/
https://www.ncbi.nlm.nih.gov/pubmed/37289491
http://dx.doi.org/10.2196/47900
work_keys_str_mv AT nisashahista leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT valleeemilie leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT marshalljonathan leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT collinsemersonjulie leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT yeungpolly leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT prinsengerard leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT douwesjeroen leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT bakermichaelg leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT wrightjackie leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT quintanya leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT holdawaymaureen leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT wilkinsondavida leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT fayazahmed leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT littlejohnstuart leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy
AT benschopjackie leptospirosisinaotearoanewzealandprotocolforanationwidecasecontrolstudy